Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • CCI approves sale,...

    CCI approves sale, restructuring of Apollo Pharmacy

    Medical Dialogues BureauWritten by Medical Dialogues Bureau Published On 2019-09-24T09:15:48+05:30  |  Updated On 29 March 2022 4:44 PM IST

    NEW DELHI: The Competition Commission on Monday said it has approved the restructuring of Apollo Hospitals Enterprise Ltd's pharmacy business and its subsequent acquisition by certain investors.


    Apollo Hospitals Enterprise Ltd (AHEL) in November 2018 had announced that it would divest its front-end pharmacy business to Apollo Pharmacy for a lump sum cash consideration of Rs 527.8 crore as part of a restructuring exercise.


    Following the transaction, Apollo Pharmacy Ltd (APL) will be a wholly-owned subsidiary of Apollo Medicals Pvt Ltd (AMPL) in which AHEL will have a 25.5 per cent stake.


    The other three investors in AMPL will be ENAM Securities with 44.7 per cent stake, Jhelum Investment Fund 1 with 19.9 per cent stake and Hemendra Kothari with 9.9 per cent stake, it had said.


    The Competition Commission of India (CCI) in a tweet on Monday said it "approves restructuring of pharmacy business of Apollo Hospitals Enterprise Limited and its subsequent acquisition by Enam Securities Private Limited, Jhelum Investment Fund I, and Hemendra Kothari".


    .@CCI_India approves restructuring of pharmacy business of Apollo Hospitals Enterprise Limited and its subsequent acquisition by Enam Securities Private Limited, Jhelum Investment Fund I, and Mr. Hemendra Kothari.

    — CCI (@CCI_India) September 23, 2019



    Under the new structure, AHEL will be the exclusive supplier for APL under a long-term supplier agreement. AHEL will enter into a brand licensing agreement with APL to license the "Apollo Pharmacy" brand to the front-end stores and online pharmacy operations.


    The move followed a review of long-term strategy for both health care services and standalone pharmacies of the company, the firm had said.


    Besides, in a separate tweet on Monday, the fair trade regulator said it "approves acquisition of up to 25.02 per cent share of Federal-Mogul Goetze by Icahn Enterprises, American Entertainment and IEH FMGI Holdings".


    Federal-Mogul Goetze is engaged in the manufacture and sale of auto components in India, used for automotive, locomotive and industrial applications, a combination notice filed with CCI said.


    Icahn Enterprises and American Entertainment Properties Corp are diversified holding companies engaged in various businesses including investment, automotive, and energy among others, while IEH FMGI Holdings is a wholly-owned subsidiary of American Entertainment, it added.


    Read Also: Apollo to separate out its pharmacy business, seeks shareholders nod


    AHELAMPLAPLApolloApollo HospitalsApollo PharmacyCCICCI clearanceCompetition Commission of IndiaENAMHemendra KothariIcahn EnterprisesMogul Goetzepharmapharma businesspharma companypharma news
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok